ARTICLE | Company News
Discovery Genomics, Immusoft deal
March 21, 2016 7:00 AM UTC
Immusoft acquired gene therapy company Discovery Genomics in a stock deal. Discovery Genomics received 22.45% of Immusoft stock. Immusoft will use its Immune System Programming technology, which repro...